Dew,
Thanks for transcript of the CC. I was pleased at what I read on a number of issues, especially that GTCB is trying to get a deal where the partner will fund and or conduct the clinical trials for rATIII in acquried deficiencies. Now, if the damn partnership will only materialize. Still, the delay and the "diversion" of the original partner could end being a plus for GTCB. Like in dating, sometimes interest goes way up when the partner feels there is competition for one's affection. Yes, I know I am a hopeless optimist.
Vinny
